Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 311,893
  • Shares Outstanding, K 20,452
  • Annual Sales, $ 19,740 K
  • Annual Income, $ 3,270 K
  • 60-Month Beta 1.35
  • Price/Sales 15.28
  • Price/Cash Flow 86.96
  • Price/Book 6.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.01
  • Number of Estimates 3
  • High Estimate 0.04
  • Low Estimate -0.02
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.78 +10.67%
on 11/14/19
19.14 -20.32%
on 11/05/19
-0.92 (-5.69%)
since 10/15/19
3-Month
13.78 +10.67%
on 11/14/19
21.18 -28.00%
on 09/19/19
-3.74 (-19.69%)
since 08/15/19
52-Week
9.15 +66.67%
on 12/21/18
22.44 -32.04%
on 03/22/19
+4.81 (+46.07%)
since 11/15/18

Most Recent Stories

More News
BioLife Solutions Acquires Custom Biogenic Systems

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the...

BLFS : 15.25 (+3.39%)
BioLife Solutions Announces Third Quarter 2019 Financial Results

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today reported financial...

BLFS : 15.25 (+3.39%)
BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500(TM)

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced that based on revenue growth from...

BLFS : 15.25 (+3.39%)
BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, ("BioLife" or the "Company"), today announced that the Company's...

BLFS : 15.25 (+3.39%)
BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced three new patents for inventions related to cryopreservation,...

BLFS : 15.25 (+3.39%)
iVexSol Announces $2M in Seed Funding

iVexSol, a newly formed viral vector manufacturing company, today announced $2.0 million in new convertible debt funding led by Casdin Capital, LLC and BioLife Solutions (NASDAQ:BLFS). The company is founded...

BLFS : 15.25 (+3.39%)
BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced a co-investment accelerator program with Casdin...

BLFS : 15.25 (+3.39%)
BioLife Solutions Announces New evo® Cold Chain Customers

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers have adopted...

BLFS : 15.25 (+3.39%)
Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced that Mustang Bio, Inc. (NASDAQ:...

BLFS : 15.25 (+3.39%)
MBIO : 2.83 (+8.85%)
BioLife Solutions Strengthens Sales Team with Key Leadership Additions

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the hiring of two key sales executives...

BLFS : 15.25 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BLFS with:

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

2nd Resistance Point 15.90
1st Resistance Point 15.58
Last Price 15.25
1st Support Level 14.84
2nd Support Level 14.42

See More

52-Week High 22.44
Fibonacci 61.8% 17.36
Fibonacci 50% 15.80
Last Price 15.25
Fibonacci 38.2% 14.23
52-Week Low 9.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar